Amneal Pharmaceuticals, Inc.
NASDAQAMRX enters this week's session caught between a fresh analyst upgrade and a stock that has shed 15% in a month — a gap that defines the current setup for Amneal Pharmaceuticals. Options positioning is the most charged signal right now. The put/call ratio jumped to 1.10 on Tuesday, more than two standard deviations above its 20-day average of 0.54 — a level consistent with heavy…
Snapshot as of 21 May 2026
AMRX enters this week's session caught between a fresh analyst upgrade and a stock that has shed 15% in a month — a gap that defines the current setup for Amneal Pharmaceuticals. Options positioning is the most charged…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AMRX — free to start on ORTEX.
Sign up for free →Open AMRX on ORTEX